These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6093624)

  • 21. Solubilization of high affinity corticotropin-releasing factor receptors from rat brain: characterization of an active digitonin-solubilized receptor complex.
    Grigoriadis DE; Zaczek R; Pearsall DM; De Souza EB
    Endocrinology; 1989 Dec; 125(6):3068-77. PubMed ID: 2555137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidermal growth factor binding and receptor distribution in term human placenta.
    Magid M; Nanney LB; Stoscheck CM; King LE
    Placenta; 1985; 6(6):519-26. PubMed ID: 3014487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ligand-induced association of epidermal growth factor receptor to the cytoskeleton of A431 cells.
    van Bergen en Henegouwen PM; Defize LH; de Kroon J; van Damme H; Verkleij AJ; Boonstra J
    J Cell Biochem; 1989 Apr; 39(4):455-65. PubMed ID: 2722972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of epidermal growth factor receptor interaction with the detergent-insoluble cytoskeleton and its effects on receptor tyrosine kinase activity.
    Gronowski AM; Bertics PJ
    Endocrinology; 1995 May; 136(5):2198-205. PubMed ID: 7720669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidermal growth factor-receptor-protein kinase interactions.
    Cohen S; Carpenter G; King L
    Prog Clin Biol Res; 1981; 66 Pt A():557-67. PubMed ID: 6273929
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and solubilization of atrial natriuretic factor receptors in human placenta.
    Sen I
    Biochem Biophys Res Commun; 1986 Mar; 135(2):480-6. PubMed ID: 3008723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An investigation of sites that bind human somatotropin (growth hormone) in the liver of the pregnant rabbit.
    Cadman HF; Wallis M
    Biochem J; 1981 Sep; 198(3):605-14. PubMed ID: 6275854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibody-induced activation of the epidermal growth factor receptor tyrosine kinase requires the presence of detergent.
    Spaargaren M; Defize LH; de Laat SW; Boonstra J
    Biochem Biophys Res Commun; 1990 Sep; 171(2):882-9. PubMed ID: 2169740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of the receptor for epidermal growth factor-urogastrone in human placenta membranes.
    Hock RA; Hollenberg MD
    J Biol Chem; 1980 Nov; 255(22):10731-6. PubMed ID: 6253485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. the stability in various detergents of transferrin-transferrin receptor complexes from reticulocyte plasma membranes.
    Nunez MT; Glass J; Cole ES
    Biochim Biophys Acta; 1981 Feb; 673(1):137-46. PubMed ID: 6258652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Affinity labeling of a transforming growth factor receptor that does not interact with epidermal growth factor.
    Massague J; Czech MP; Iwata K; DeLarco JE; Todaro GJ
    Proc Natl Acad Sci U S A; 1982 Nov; 79(22):6822-6. PubMed ID: 6294655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detergent solubilization of the EGF receptor from A431 cells.
    Dayanidhi R; Rintoul DA
    Trans Kans Acad Sci; 1993 Apr; 96(1-2):28-34. PubMed ID: 11537708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of a monoclonal antibody against hEGF with a receptor site for EGF.
    Valente S; Souto B; Balter H; Welling MM; Román E; Robles A; Pauwels EK
    Nucl Med Biol; 1999 Nov; 26(8):937-42. PubMed ID: 10708308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Solubilization and isolation of the human placenta receptor for epidermal growth factor-urogastrone.
    Hock RA; Nexø E; Hollenberg MD
    J Biol Chem; 1980 Nov; 255(22):10737-43. PubMed ID: 6253486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Purification of an active EGF receptor kinase with monoclonal antireceptor antibodies.
    Yarden Y; Harari I; Schlessinger J
    J Biol Chem; 1985 Jan; 260(1):315-9. PubMed ID: 2578126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Purification of the epidermal growth factor receptor by tyrosine-Sepharose affinity chromatography.
    Akiyama T; Kadooka T; Ogawara H
    Biochem Biophys Res Commun; 1985 Aug; 131(1):442-8. PubMed ID: 2994662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The extracellular domain of the epidermal growth factor receptor. Studies on the affinity and stoichiometry of binding, receptor dimerization and a binding-domain mutant.
    Brown PM; Debanne MT; Grothe S; Bergsma D; Caron M; Kay C; O'Connor-McCourt MD
    Eur J Biochem; 1994 Oct; 225(1):223-33. PubMed ID: 7925442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Growth-inhibitory effects of epidermal growth factor and overexpression of its receptors on human squamous cell carcinomas in culture.
    Kamata N; Chida K; Rikimaru K; Horikoshi M; Enomoto S; Kuroki T
    Cancer Res; 1986 Apr; 46(4 Pt 1):1648-53. PubMed ID: 3004701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Binding sites for epidermal growth factor in human fetal membranes.
    Rao CV; Carman FR; Chegini N; Schultz GS
    J Clin Endocrinol Metab; 1984 Jun; 58(6):1034-42. PubMed ID: 6327749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics and distribution of receptors for [D-TRP6]-luteinizing hormone-releasing hormone, somatostatin, epidermal growth factor, and sex steroids in 500 biopsy samples of human breast cancer.
    Fekete M; Wittliff JL; Schally AV
    J Clin Lab Anal; 1989; 3(3):137-47. PubMed ID: 2569034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.